{"id":"W2096008082","doi":"10.1186/1710-1492-10-7","title":"Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab","year":2014,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Omalizumab; Tolerability; Medicine; Food allergy; Oral food challenge; Placebo; Allergy; Allergen; Desensitization (medicine); Internal medicine; Adverse effect; Immunology; Antibody; Immunoglobulin E; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001495354,0.000204632,0.0008429617,0.000162734,0.00008719691,0.00001186932,0.0001442241,0.0003358948,0.00007477656],"category_scores_gemma":[0.001297287,0.000171118,0.000123712,0.0002566284,0.0005910262,0.00006912199,0.0001874485,0.0004990142,0.000004081804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003007938,"about_ca_system_score_gemma":0.0001094926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007235338,"about_ca_topic_score_gemma":0.001211255,"domain_scores_codex":[0.9970452,0.0006082362,0.001229258,0.000549299,0.0001631736,0.0004048438],"domain_scores_gemma":[0.998354,0.0007027047,0.0001667404,0.0004750753,0.0001318826,0.0001696305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1490803,0.006582357,0.01228472,0.000120355,0.0008853986,0.00004477198,0.0006137998,0.00002644906,0.02421406,0.00122039,0.00006347343,0.8048639],"study_design_scores_gemma":[0.1109117,0.04013071,0.5115927,0.0003376125,0.000005583081,0.000099715,0.0002802168,0.008238693,0.001838216,0.0004519022,0.3256484,0.0004645726],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905711,0.0001413581,0.0003219576,0.001112359,0.00007047597,0.00716633,0.00001036643,0.00002235544,0.0005836435],"genre_scores_gemma":[0.9967762,0.0001828604,0.001668295,0.000292175,0.00005851682,0.0008642249,0.00001252282,0.00002131014,0.0001239076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8043994,"threshold_uncertainty_score":0.697799,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04964551039162127,"score_gpt":0.4152387035204501,"score_spread":0.3655931931288288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}